Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Bicara Therapeutics Inc. is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Its lead program, ficerafusp alfa, is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor (EGFR), directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b). Through this dual-targeting mechanism, ficerafusp alfa has the potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and proliferation and the immunosuppressive TGF-b signaling within the tumor microenvironment. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need. Its platform is designed to facilitate the development of bifunctional therapies that precisely target the tumor and deliver a tumor-modulating payload to the tumor site.
Find out what a historical investment in Bicara Therapeutics would be worth today using our BCAX stock calculator.
Buying BCAX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Bicara Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BCAX
What is the ticker symbol of Bicara Therapeutics?
The ticker symbol for Bicara Therapeutics is BCAX.
How much is one share of BCAX?
One share of BCAX is valued at $9.12 as of 20 November 2026.
What is the market capitalisation of Bicara Therapeutics BCAX?
As of 20 November 2026 Bicara Therapeutics has a market cap of $622.71M.
What is the 52-week high for Bicara Therapeutics stock?
The Bicara Therapeutics 52-week high stock price is $30.99.
What is the 52-week low for Bicara Therapeutics stock?
The Bicara Therapeutics 52-week low stock price is $7.87.
Can I buy BCAX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BCAX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BCAX on Stake
Buy BCAX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of BCAX from only US$10 with fractional shares